[Congressional Record (Bound Edition), Volume 149 (2003), Part 15]
[Senate]
[Page 20875]
[From the U.S. Government Publishing Office, www.gpo.gov]




                    AUTHORITY FOR COMMITTEES TO MEET


                       committee on the judiciary

  Mr. TALENT. Mr. President, I ask unanimous consent that the Committee 
on the Judiciary be authorized to meet to conduct a hearing on Friday, 
August 1, 2003, at 9:30 a.m., in the Dirksen Senate Office Building 
Room 226 on ``Examining the Senate and House Versions of the `Greater 
Access to Pharmaceuticals Act'.''

     Witness List

  Panel I: The Honorable Timothy J. Muris, Esq., Chairman, Federal 
Trade Commission, Washington, DC; Mr. Jon W. Dudas, Deputy Under 
Secretary for Intellectual Property, Deputy Director of the United 
States Patent and Trademark Office, Department of Commerce, Arlington, 
Virginia; Mr. Dan Troy, Esq., Chief Counsel for Food and Drugs, Food 
and Drug Administration, Rockville, MD; and Mr. Sheldon T. Bradshaw, 
Deputy Assistant Attorney General, Office of Legal Counsel, Department 
of Justice, Washington, DC.
  Panel II: Mr. Robert Armitage, Vice President and General Counsel, 
Eli Lilly and Company, Washington, DC.
  The PRESIDING OFFICER. Without objection, it is so ordered.

                          ____________________